Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions PART 1 Part 1 of "Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions" is now out in the The Journal of Nuclear Medicine - JNM. This publication

Radiopharmaceutical supply chain structure: 7/7 Final Step – Delivery to the Hospital and Administration to the Patient The last mile: where the supply chain finally meets the patient   Most medicines wait for the patient. A radiopharmaceutical

Radiopharmaceutical supply chain structure: 6/7 Step 6 – Drug Manufacturing Manufacturing: the often-overlooked bottleneck   When discussing radiopharmaceutical supply chains, supply concerns are often reduced to radionuclide availability. While securing isotope production remains essential, manufacturing capabilities have

Radiopharmaceutical supply chain structure: 5/7 Step 5 – Radionuclide Processing 🌐 The processing integration : moving from standalone assets to coupled supply chainsRadionuclide processing plays a central role in the radiopharmaceutical supply chain, transforming raw irradiation output (irradiated

Radiopharmaceutical supply chain structure: 4/7 Step 4 – Target Irradiation🌐 The Irradiation challenge : How the industry is securing the next generation of radionuclides Moving from targetry to the actual irradiation stage of radionuclide production requires a careful

Radiopharmaceutical supply chain structure: 3/7 Step 3 – Target Manufacturing and Preparation 🧪Transitioning from isotopic enrichment to the physical preparation of materials introduces one of the most critical engineering constraints in the supply chain: targetry.Target design and